Your browser doesn't support javascript.
loading
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy.
Dolton, Garry; Rius, Cristina; Wall, Aaron; Szomolay, Barbara; Bianchi, Valentina; Galloway, Sarah A E; Hasan, Md Samiul; Morin, Théo; Caillaud, Marine E; Thomas, Hannah L; Theaker, Sarah; Tan, Li Rong; Fuller, Anna; Topley, Katie; Legut, Mateusz; Attaf, Meriem; Hopkins, Jade R; Behiry, Enas; Zabkiewicz, Joanna; Alvares, Caroline; Lloyd, Angharad; Rogers, Amber; Henley, Peter; Fegan, Christopher; Ottmann, Oliver; Man, Stephen; Crowther, Michael D; Donia, Marco; Svane, Inge Marie; Cole, David K; Brown, Paul E; Rizkallah, Pierre; Sewell, Andrew K.
Afiliación
  • Dolton G; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Rius C; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Wall A; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Szomolay B; Systems Immunology Research Institute, Cardiff, Wales CF14 4XN, UK.
  • Bianchi V; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Galloway SAE; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Hasan MS; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Morin T; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Caillaud ME; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Thomas HL; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Theaker S; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Tan LR; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Fuller A; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Topley K; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Legut M; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Attaf M; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Hopkins JR; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Behiry E; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Zabkiewicz J; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Alvares C; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Lloyd A; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Rogers A; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Henley P; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Fegan C; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Ottmann O; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Man S; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Crowther MD; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Cole DK; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Brown PE; The Zeeman Institute, University of Warwick, Coventry CV4 7AL, UK.
  • Rizkallah P; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.
  • Sewell AK; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK; Systems Immunology Research Institute, Cardiff, Wales CF14 4XN, UK. Electronic address: sewellak@cardiff.ac.uk.
Cell ; 186(16): 3333-3349.e27, 2023 08 03.
Article en En | MEDLINE | ID: mdl-37490916
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Proteómica / Antígenos de Neoplasias / Neoplasias Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Proteómica / Antígenos de Neoplasias / Neoplasias Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos